Contact: Carolyn Fong
National University of Singapore
Caption: A research team led by Assoc Prof Christoph Winkler (right) and Dr Kelvin See (left) identified Neurexin2 as a novel target for potential therapy of neurodegeneration in Spinal Muscular Atrophy patients.
Credit: Yu Tingsheng
Usage Restrictions: To add in image credit
Related news release: Study led by NUS scientists provides new insights into cause of human neurodegenerative disease